EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as

1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda. Senaste om SEB A: Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.

Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC. Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture morgondagens industri. Välkommen till morgondagens industri. Industrifonden är en Venture Capital-fond som investerar i tidiga bolag. Vi är baserade i Sverige men har en räckvidd över hela Norden.

January 21, 2021 .

2021-02-11

The founding team behind EnginZyme – Karim Engelmark Cassimjee, Robin Chatterjee and Samuel Härgestam – is driven by the vision of a chemical industry free from the dependency with petrochemicals, toxic syntheses and polluting processes. 2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden.

The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.

News . 2021-02-11 EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden.

– EnginZyme is developing a technology platform for sustainable production of chemicals. – The company has produced catalysts at multi-kilogram scales EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes. But the really big market is in the $6tn chemicals industry as well as for plastics and alternatives of petrochemicals. EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M)..
Stalla pa fordon

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.

EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme is a biotechnology company that specializes in biocatalysis.
Arbetsmarknadspolitisk åtgärd

Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A. February 1, 2021 . Thesis . Synthetic Biology – enabling the nascent bioeconomy. January 21, 2021 . News .

The Stockholm-based company has just raised an €11m Series A extension round from Industrifonden, the Swedish government-backed VC, in order to get the technology out of the lab and into manufacturing companies. 2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste. Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm, followed by SEB Greentech VC and existing shareholders.

Industrifonden leads €4.6m extended series-A for EnginZyme. Latest round brings company's total series-A funding to €11m. Early-stage; 12 February 2021.

Try Pro free Solutions.

Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company).